【难治性高血压新药取得突破!阿斯利康(AZN.US)潜在重磅疗法Baxdrostat临床试验告捷】智通财经APP获悉,阿

智通财经
Jul 14, 2025
【难治性高血压新药取得突破!阿斯利康(AZN.US)潜在重磅疗法Baxdrostat临床试验告捷】智通财经APP获悉,阿斯利康(AZN.US)近日宣布,其试验阶段的高血压药物Baxdrostat能有效降低难治性或控制不佳的高血压患者的血压,为这款潜在“重磅炸弹”药物的发展前景注入强心针。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10